Barton F. Haynes

Duke University

Public scientific profile · Unclaimed

Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.

Top expertise

  • HIV Research and Treatment

    Strong evidence · 9 supporting papers · latest 2026

  • T-cell and B-cell Immunology

    Strong evidence · 6 supporting papers · latest 2026

  • Immunotherapy and Immune Responses

    Strong evidence · 7 supporting papers · latest 2026

  • Virology and Viral Diseases

    Strong evidence · 1 supporting paper · latest 2026

  • vaccines and immunoinformatics approaches

    Solid evidence · 5 supporting papers · latest 2026

  • Influenza Virus Research Studies

    Solid evidence · 1 supporting paper · latest 2026

  • Immune Cell Function and Interaction

    Solid evidence · 1 supporting paper · latest 2026

  • HIV/AIDS drug development and treatment

    Solid evidence · 2 supporting papers · latest 2026

Publications (15)

  • Humans and rhesus macaques share maturation pathways of HIV-1 envelope-reactive V3-glycan bnAb lineages

    2026DOIPMID 42418555

  • Mechanistic and antigenic boundaries of Henipavirus and Parahenipavirus glycoproteins

    2026DOIPMID 42321170

  • Rapid vaccine induction of macaque HIV-1 V2 Apex broadly neutralizing antibodies with immunogenetic signatures that are potentially translatable to humans

    2026DOI

  • B Cell Receptor Signaling Sets Boundaries for Selection of Broadly Neutralizing Antibody Functional Mutations

    2026DOI

  • Functional Convergence of Genetically Diverse B-Cell Receptors in Simian-HIV Infected Rhesus Macaques

    2026DOI

  • Functional Convergence of Genetically Diverse B-Cell Receptors in Simian-HIV Infected Rhesus Macaques

    2026DOI

  • Asymmetric Boost Responses to an HIV-1 Vaccine: Boost-site Controls Secondary B-cell Fates

    2026DOI

  • Induction of HIV broadly neutralizing antibodies with vaccination in humans in discovery medicine trials

    2026DOIPMID 42740473

  • A phase 1 randomized controlled trial to evaluate the safety and immunogenicity of a HIV monomeric gp120 protein B-cell lineage targeting HIV vaccine in healthy adults

    2026DOIPMID 42245034

  • Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design

    2026DOIPMID 42096521

  • Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies

    2026DOIPMID 42380659

  • Elicitation of stem-directed antibodies in rhesus macaques by a conventional hemagglutinin immunogen

    2026DOIPMID 42539121

  • Antibodies against HLA-E-VL9 enhance NK cell and CD8+ T cell cytotoxicity against tumor cells and HIV-infected CD4+ T cells.

    2026DOIPMID 42748220

  • Reviewer #1 (Public review): Functional Convergence of Genetically Diverse B-Cell Receptors in Simian-HIV Infected Rhesus Macaques

    2026DOI

  • Reviewer #2 (Public review): Functional Convergence of Genetically Diverse B-Cell Receptors in Simian-HIV Infected Rhesus Macaques

    2026DOI

Organizations in sourced records

Affiliation evidence only — not confirmed current employment.

  • Duke University

Source: OpenAlex · retrieved 2026-09-27

Are you Barton F. Haynes? Sign in to claim this profile